arrow_back Back to App

Extending funding for Type 1 diabetes programs until 2028.

This act extends funding for special programs supporting individuals with Type 1 diabetes. This means that resources for research and patient support will be available for another five years, potentially improving care and access to new therapies.
Key points
Funding for Type 1 diabetes programs will be extended until 2028.
This ensures continued support and research for individuals affected by this condition.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_2550
Sponsor: Rep. DeGette, Diana [D-CO-1]
Process start date: 2023-04-10
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Special Diabetes Program Reauthorization Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_2550.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-04-10.

What are the main provisions?

Key points include:

  • Funding for Type 1 diabetes programs will be extended until 2028.
  • This ensures continued support and research for individuals affected by this condition.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. DeGette, Diana [D-CO-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health